Drug: methotrexate Quarter: 2016Q3
Total Records: 3,574 Number of Pages: 179
DRUGNAME | PT | EventCount |
---|---|---|
METHOTREXATE (TRADE NAME UNKNOWN) | Frustration tolerance decreased | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Full blood count decreased | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Gastric disorder | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Gastrointestinal haemorrhage | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | General physical health deterioration | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Goitre | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Graft versus host disease | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Graft versus host disease in gastrointestinal tract | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Graft versus host disease in skin | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Haematemesis | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Haemoptysis | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Haemorrhagic cyst | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Hair growth abnormal | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Hand deformity | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Hepatic cirrhosis | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Hepatic failure | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Hepatic fibrosis | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Hepatic function abnormal | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Hepatic steatosis | 1 |
METHOTREXATE (TRADE NAME UNKNOWN) | Hepatocellular injury | 1 |
Total Records: 3,574 Number of Pages: 179